Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Carcinoma, Epidermoid

dichlororibofuranosylbenzimidazole has been researched along with Carcinoma, Epidermoid in 2 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Research Excerpts

ExcerptRelevanceReference
"In this study, oral squamous carcinoma cells (SCC2/88) had a two-fold increase in PTHrP mRNA stability (from 45 to 90 min) in response to treatment with TGFbeta1."1.31Messenger RNA stability of parathyroid hormone-related protein regulated by transforming growth factor-beta1. ( Capen, CC; Rosol, TJ; Sellers, RS, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, YW1
Chen, BK1
Chen, CJ1
Arakawa, T1
Yoshimoto, T1
Yamamoto, S1
Chang, WC1
Sellers, RS1
Capen, CC1
Rosol, TJ1

Other Studies

2 other studies available for dichlororibofuranosylbenzimidazole and Carcinoma, Epidermoid

ArticleYear
Epidermal growth factor enhances transcription of human arachidonate 12-lipoxygenase in A431 cells.
    Biochimica et biophysica acta, 1997, Jan-07, Volume: 1344, Issue:1

    Topics: Arachidonate 12-Lipoxygenase; beta-Galactosidase; Carcinoma, Squamous Cell; Cytosol; Dactinomycin; D

1997
Messenger RNA stability of parathyroid hormone-related protein regulated by transforming growth factor-beta1.
    Molecular and cellular endocrinology, 2002, Feb-25, Volume: 188, Issue:1-2

    Topics: 3' Untranslated Regions; Animals; Carcinoma, Squamous Cell; Cell-Free System; Cross-Linking Reagents

2002